Kalbe Farma Tbk vs WIR ASIA Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while WIR ASIA Tbk. trades at Rp53 (market cap 632.75B, 74.95M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 52.2× WIR ASIA Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 74.95M). Which is the better fit depends on your goals.
| KLBF | WIRG | |
|---|---|---|
Market Cap | 33T | 632.75B |
Volume | 98.44M | 74.95M |
Lot | 984.38K | 749.53K |
Turnover | 70.64B | 3.97B |
Average Price | 717.58 | 53.02 |
Value | 70.64B | 3.97B |
Indicative Equilibrium Price | 720 | 53 |
Indicative Equilibrium Volume | 43.62K | 23.65K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →